Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_provenance.
- lhgdn-20090331 importedOn "2009-03-31" NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_provenance.
- NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_assertion wasGeneratedBy ECO_0000203 NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_provenance.
- NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_assertion wasDerivedFrom lhgdn-20090331 NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_provenance.
- NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_assertion SIO_000772 18697202 NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_provenance.
- NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_assertion evidence source_evidence_literature NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_provenance.
- NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_assertion description "[hypermethylation of CDH1 and integrin alpha4 genes may be used as recurrence-associated prognostic indicators in stage I and stage II esophageal squamous cell carcinoma, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162455.RAeQSRJ79kdP5S7hwKbY1itjf_P9M3xUsZJDf3QssxU4A130_provenance.